# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Oct 5, 2023

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2023-10-05
- Accepted by EDGAR: Oct 5, 2023, 16:04 ET
- Period: 2023-10-05
- Accession: 0001104659-23-107161
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000110465923107161/tm2327767d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000110465923107161/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000110465923107161/tm2327767d1_8k.htm

Filed Oct 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-107161. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.